Veterinary Medicines

HIPRAVIAR-TRT 4, Injekční emulze

Authorised
  • Infectious bursal disease virus, strain Winterfield 2512, Live
  • Newcastle disease virus, strain La Sota, Inactivated
  • Avian infectious bronchitis virus, strain H52, Inactivated
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
Download as PDF

Product identification

Medicine name:
HIPRAVIAR-TRT 4, Injekční emulze
Active substance:
  • Infectious bursal disease virus, strain Winterfield 2512, Live
  • Newcastle disease virus, strain La Sota, Inactivated
  • Avian infectious bronchitis virus, strain H52, Inactivated
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
Target species:
  • Turkey
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain Winterfield 2512, Live
    329.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Newcastle disease virus, strain La Sota, Inactivated
    16.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, strain H52, Inactivated
    288.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
    195.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Turkey
      • Meat and offal
        0
        day
      • Egg
        0
        day
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 97/073/04-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."